RHP Risk Management Guides Industry Through Shift to New Toxicology and Risk Assessment Methodologies
As regulators expand the use of human-relevant testing, companies face new challenges in toxicology and risk assessment. RHP Risk Management provides expertise to support regulatory and risk management decisions.
RHP Risk Management is assisting companies in navigating the evolving regulatory landscape, particularly in toxicology and risk assessment. Regulatory bodies globally are increasing their adoption of human-relevant testing approaches, presenting new challenges for businesses to ensure methods are fit-for-purpose and capable of supporting defensible regulatory and risk management decisions.
Regulatory changes in the U.S., enacted in June 2026, have accelerated the shift toward these new methodologies. This development requires companies to possess a deeper understanding of the validity and reliability of these novel approaches. RHP Risk Management offers expert guidance in selecting and applying these methods.
The firm's specialists aid clients in identifying the most suitable methods that meet regulatory requirements and support business objectives. The aim is to ensure that companies can make informed and defensible assessments in line with new testing standards.
The transition to more human-relevant methodologies signifies a significant step towards more accurate and ethical risk assessment. RHP Risk Management supports businesses through this transition with consultation and strategic advice, enabling them to adapt to new regulatory demands and ensure product safety.